$1.29 million in fiscal second quarter revenue Clinics see continued surge in demand for mental health services Ongoing expansion of clinic capacity TORONTO, ON / ACCESSWIRE / March 1, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF) (“Novamind” or “the Company”), a leading mental health company specialized in psychedelic medicine, today reported its fiscal second quarter results for the three months…


Previous articleOnline Psychedelic Community Options to Ride Out the Rest of Covid-19
Next articleFinding the Psychedelic Sweet Spot